Vaccine compositions comprising hepatitis B antigen 3-O-deacylated monophosphoryl lipid A and aluminum phosphate

摘要

PCT No. PCT/EP96/00681 Sec. 371 Date Oct. 27, 1997 Sec. 102(e) Date Oct. 27, 1997 PCT Filed Feb. 15, 1996 PCT Pub. No. WO96/26741 PCT Pub. Date Sep. 6, 1996A novel vaccine formulation is provided, comprising a hepatitis B component, particularly hepatitis B surface antigen, in combination with aluminum phosphate and 3-O-acylated monophosphoryl lipid A.